Major Growth Drivers:

What are the underlying market drivers?

• Growing biologics and advanced therapies pipeline: As monoclonal antibodies, cell and gene therapies
• Preference for single-use and modular manufacturing systems: Single-use bioprocess containers have investment is lower, the time to validate is shorter, and the risk of contamination is lower than traditional stainless-steel systems. In addition, the single-use bioprocess containers can be used in either new or retrofit facilities which have the possibility of being more flexible and cost effective.
• Growth of contract manufacturing and outsourcing: As the rise of biotech firms outsourcing development and manufacturing to CDMOs/CROs
• Geographic expansion and consumer market entry: Biomanufacturing infrastructure is being invested in throughout Asia-Pacific and other emerging regions and there are new production sites, as well as new consumers and markets coming into magnitude for modern containment solutions. If the government and the industry can support capacity expansion, there will bioprocess container uptake.

  Key Drifts:

  What new Trends are Driving Change in the Market?

  Smart and integrated bioprocess containers with sensors, RFID tagging and data connectivity will (be) become more widespread, allowing real-time monitoring and more effective operations. Some manufacturers are developing bio-based films, recyclable materials and designs minimizing waste in bioprocess containers to help customers meet corporate sustainability goals, on demand and in compliance with regulatory pressure.

  3D container formats with larger volumes will increase to accommodate the volumes of media, buffer and bulk processing needed to support commercial biologics manufacturing. Modular and plug-and-play cleanroom systems that are pre-configured with single-use bioprocess containers are on the rise
  Become a valued research partner with us -

  Significant Challenge:

  Whether regarding bioprocess containers, or other single-use systems, the environmental pressure associated with waste and disposal represents one of the biggest challenges for the bioprocess containers market. While bioprocess containers have operational value, the sustainability design challenges of utilizing polymer films and plastics raises the concern for waste, regulatory scrutiny, and added waste-management costs. Until manufacturers develop more sustainable materials, recycling programs or circular-economy models to lessen the environmental pressure, this challenge is likely to lower adoption.

  Regional Analysis:

  North America is the leading region in the bioprocess containers market by 41% share, primarily attributed to the matured biopharmaceutical sector of the region characterized by an overwhelming number of biologics market players

  The high R&D spend for biologics and adoption of flexible manufacturing technologies, alongside the existence of global players, supports North America's dominance. Additionally, North America's advantage of adopting modular facilities and the ability to reconfigure processes to rapidly respond to emergent needs, such as pandemic-level vaccine production, supports continued dominance with this sector.

  Asia-Pacific is the fastest-growing segment of the bioprocess containers market since there is increasing investment in biomanufacturing, local biologics and biosimilars capacity expansion cell therapies

  At the same time, outsourcing of manufacturing from global players into Asia-Pacific and cost advantages that the region provides are also accelerating that uptake. Regulatory reforms and initiatives are also further developing the local biotech ecosystems to support adoption of single-use bioprocess container technologies. Throughout this transition from contract manufacturing to end-to-end biomanufacturing, the need for flexible and scalable manufacturing container solutions continues grow.

  Get the latest insights on life science industry segmentation with our Annual Membership:

  Segmental Insights:

  By type:

  The 2D bioprocess containers (flat-bag, film-based formats) was the largest contributor to revenue in 2024 among the various types, as these containers are often compatible with several types of media and buffer applications and can more easily be incorporated into existing production lines. Additionally, most manufacturers have become accustomed to utilizing 2D systems over the decades.

  The 3D container formats (cube or rectangular tanks) are the only category predicted to grow significantly more than the other types of containers, as they will support larger volumes or bulk media preparation and storage, as well as support large-scale commercial manufacturing capabilities.

  By Application:

  In 2024, the upstream process segment was the largest application segment in the bioprocess container market. Upstream processes, which include cell culture, media preparation and fermentation, were the biggest share of the bioprocess containers market in 2024 because bioprocess containers are key for media and expansion of cells as well as initial bioreactor feeding in single-use/sterile operations.

  In terms of application, the production process segment is projected to be the fastest growing during the forecast period. The production process segment, which includes large-scale harvest, buffer handling, downstream integration and formulation, is projected to grow the fastest as operations are shifting to scalable commercial manufacturing with higher volumes and larger containers/flexible formats.

  By End-Use:

  In terms of end-use, the pharmaceutical (and biopharmaceutical) companies segment accounted for the largest share of the bioprocess container market in 2024. These companies consumed the largest share of bioprocess containers to support their more extensive biologics manufacturing footprint, higher sterility requirement of their flexible systems, and their role in infusion of capital as we invest in infrastructure.

  In terms of end-use, the biotechnology companies' segment is expected to grow the fastest from 2025-2034. Biotechnology firms (cell and gene therapy firms, niche biologics developers) are expected to grow the fastest due to their increasing outsourcing of manufacturing, adoption of single use system (SUS) containers, and need for more mobile, small to mid-size container solutions as they commercialize.

  Recent Developments:

  April 15, 2025, Thermo Fisher Scientific, Inc. launched the 5 L DynaDrive Single-Use Bioreactor, enabling seamless scale-up from lab to larger manufacturing scale while integrating sustainable film technologies and supporting faster development workflows.

  Browse More Insights of Towards Healthcare:

  The global bioprocess automation market

  The global bioprocess bags market

  The global bioprocess analyzers market

  The global upstream bioprocessing market

  The global continuous bioprocessing market

  The global single-use downstream bioprocessing market

  The sustainable bioprocessing materials market

  The global portable bioprocessing bioreactors market

  Bioprocess Containers Market Key Players List:

  • Sartorius AG (Germany)
  • Thermo Fisher Scientific Inc. (U.S.)
  • Merck KGaA (Germany)
  • Danaher Corporation (U.S.)
  • Saint-Gobain (France)
  • Meissner Filtration Products, Inc. (U.S.)
  • Single Use Support (U.S.)
  • Entegris (U.S.)
  • CellBios (India)
  • Lonza (Switzerland)

  Segments Covered in the Report

  By Type

  • 2D Container
  • 3D Container
  • Accessories
    

  By Application

  • Upstream Process
  • Production Process
  • Downstream Process
    

  By End-use

  • Pharmaceutical Companies
  • Biotechnology Companies

  By Region

  • North America
    • U.S.
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Thailand
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Sweden
    • Denmark
    • Norway
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • UAE
    • Saudi Arabia
    • Kuwait
      
  Immediate Delivery Available | Buy This Premium Research @

  Access our exclusive, data-rich dashboard dedicated to the healthcare market - built specifically for decision-makers, strategists, and industry leaders. The dashboard features comprehensive statistical data, segment-wise market breakdowns, regional performance shares, detailed company profiles, annual updates, and much more. From market sizing to competitive intelligence, this powerful tool is one-stop solution to your gateway.

  Access the Dashboard:

  About Us

  Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics, with a strong emphasis on life science research
  You can place an order or ask any questions, please feel free to contact us at ...

  Europe Region: +44 778 256 0738

  North America Region: +1 8044 4193 44

  APAC Region: +91 9356 9282 04

  Web:

  Our Trusted Data Partners

  Precedence Research | Statifacts | Towards Packaging | Towards Automotive | Towards Food and Beverages | Towards Chemical and Materials | Towards Consumer Goods | Towards Dental | Towards EV Solutions | Nova One Advisor | Healthcare Webwire | Packaging Webwire | Automotive Webwire | Nutraceuticals Func Foods | Onco Quant | Sustainability Quant | Specialty Chemicals Analytics
  Find us on social platforms: LinkedIn | Twitter | Instagram | Medium | Pinterest